東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

The economic value of new treatments...

Conti, Rena Marie.

Linked to FindBook

Google Book

Amazon

博客來

The economic value of new treatments for depression.

Record Type:	Language materials, printed : Monograph/item
Title/Author:	The economic value of new treatments for depression./
Author:	Conti, Rena Marie.
Description:	110 p.
Notes:	Adviser: Richard G. Frank.
Contained By:	Dissertation Abstracts International67-12A.
Subject:	Economics, General. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3245121

The economic value of new treatments for depression.
Conti, Rena Marie.

The economic value of new treatments for depression. - 110 p.

Adviser: Richard G. Frank.

Thesis (Ph.D.)--Harvard University, 2006.

This dissertation focuses on a number of important questions in health policy and health economics: What is the impact of illness on public programs and individuals working lives? What is the value of medical innovation given high and growing spending on it for individuals and society? How are new treatments used in clinical practice and what can this say about quality of care and efforts to better rationalize use?Subjects--Topical Terms:

1017424
Economics, General.

The economic value of new treatments for depression.
LDR:03083nam 2200289 a 45 001 951155
005 20110609
008 110609s2006 eng d
035 $a (UMI)AAI3245121
035 $a AAI3245121
040 $a UMI $c UMI
100 1 $a Conti, Rena Marie. $3 1275138
245 1 4 $a The economic value of new treatments for depression.
300 $a 110 p.
500 $a Adviser: Richard G. Frank.
500 $a Source: Dissertation Abstracts International, Volume: 67-12, Section: A, page: 4624.
502 $a Thesis (Ph.D.)--Harvard University, 2006.
520 $a This dissertation focuses on a number of important questions in health policy and health economics: What is the impact of illness on public programs and individuals working lives? What is the value of medical innovation given high and growing spending on it for individuals and society? How are new treatments used in clinical practice and what can this say about quality of care and efforts to better rationalize use?
520 $a All papers focus on depression. This focus was chosen for a variety of reasons. Depression is a prevalent chronic condition nationally and worldwide associated with high rates of disability. New treatments, specifically pharmaceutical treatments, have been a particularly prominent success story since the late 1980s. The availability of newer medications has increased the treated prevalence of depression dramatically over the past decade. New antidepressants are consistently featured in the top 20 pharmaceutical agents for spending in the private and public sectors. Despite this, patients, physicians and policy makers worry over the quality of care provided. Finally, mental health care is a case where the defining issues of health policy and health economics are present to a great degree. Focusing on depression and its treatment allows a graduate student to grapple with the theoretical and empirical challenges to the efficient and equitable provision of care.
520 $a The first paper, joint with Richard Frank and Ernie Berndt, investigates the impact of depression on the labor market activities of older workers. We find that depression increases retirement and public program claims to a similar degree as physical illness. The second paper focuses on estimating the economic value of new antidepressant for individuals and society. I find that new antidepressants used for the treatment of major depression provide value for the money spent on them for consumers and society. The third paper, joint with David Cutler and Alisa Busch, investigates the varied uses of antidepressant medications and associated costs for public and private payers. We find that antidepressants are used in the general adult population for a variety of conditions and durations divergent from existing clinical evidence.
590 $a School code: 0084.
650 4 $a Economics, General. $3 1017424
650 4 $a Health Sciences, Mental Health. $3 1017693
690 $a 0347
690 $a 0501
710 2 $a Harvard University. $3 528741
773 0 $t Dissertation Abstracts International $g 67-12A.
790 $a 0084
790 1 0 $a Frank, Richard G., $e advisor
791 $a Ph.D.
792 $a 2006
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3245121